Skip to content
EHA 2010 logo

EHA 2010

2 interviews

European Hematology Association Congress

Interviews and expert commentary from EHA 2010 — study authors and key opinion leaders discuss the findings and their clinical implications.

Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World

Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World

Big improvements in survival among patients with multiple myeloma were reported at the European Hematology Association annual congress in Barcelona by Greek researchers looking at the past decade of t

28 June 2010
Rituximab Maintenance Cuts Follicular Lymphoma Recurrence Risk In Half — Phase III PRIMA Study Results

Rituximab Maintenance Cuts Follicular Lymphoma Recurrence Risk In Half — Phase III PRIMA Study Results

Patients in the PRIMA study who had achieved remissions for their follicular lymphoma by means of immunochemotherapy had only half the risk of recurrence if they also received maintenance therapy with

28 June 2010